Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Second Quarter 2015 Financial Results by longitudeadmin | Aug 6, 2015 | Portfolio News
Corcept Therapeutics Announces Second Quarter 2015 Results and Provides Corporate Update by longitudeadmin | Aug 5, 2015 | Portfolio News
Aimmune Therapeutics Announces Pricing of Initial Public Offering by longitudeadmin | Aug 5, 2015 | Portfolio News
Jazz Pharmaceuticals Announces Second Quarter 2015 Financial Results by longitudeadmin | Aug 5, 2015 | Portfolio News
FamilyCord Announces Acquisition of LifeLine Cryogenics by longitudeadmin | Aug 4, 2015 | Portfolio News
